Gokhan Yahioglu
Oprichter bij Antikor Biopharma Ltd.
Profiel
Gokhan Yahioglu is the founder of Antikor Biopharma Ltd.
which was founded in 2001, where he holds the title of Technical Director.
Currently, he is a Principal at Imperial College London since 1997.
In the past, he worked as a Principal at the University of Cambridge.
Dr. Yahioglu received a doctorate degree from Brunel University.
Actieve functies van Gokhan Yahioglu
| Bedrijven | Functie | Begin |
|---|---|---|
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Oprichter | 01-03-2001 |
| Imperial College London | Corporate Officer/Principal | 01-01-1997 |
Eerdere bekende functies van Gokhan Yahioglu
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Opleiding van Gokhan Yahioglu
| Brunel University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |
